House Energy & Commerce To Continue Foraging Through Vytorin Data

The House Energy & Commerce Committee intends to keep hounding Merck and Schering-Plough for data and internal communications on how the company handled the release of information from three trials on Vytorin (simvastatin/ezetimibe)